Literature DB >> 25703460

Obesity and extent of emphysema depicted at CT.

S Gu1, R Li2, J K Leader1, B Zheng3, J Bon4, D Gur1, F Sciurba4, C Jin5, J Pu6.   

Abstract

AIM: To investigate the underlying relationship between obesity and the extent of emphysema depicted at CT. METHODS AND MATERIALS: A dataset of 477 CT examinations was retrospectively collected from a study of chronic obstructive pulmonary disease (COPD). The low attenuation areas (LAAs; ≤950 HU) of the lungs were identified. The extent of emphysema (denoted as %LAA) was defined as the percentage of LAA divided by the lung volume. The association between log-transformed %LAA and body mass index (BMI) adjusted for age, sex, the forced expiratory volume in one second as percent predicted value (FEV1% predicted), and smoking history (pack years) was assessed using multiple linear regression analysis.
RESULTS: After adjusting for age, gender, smoking history, and FEV1% predicted, BMI was negatively associated with severe emphysema in patients with COPD. Specifically, one unit increase in BMI is associated with a 0.93-fold change (95% CI: 0.91-0.96, p<0.001) in %LAA; the estimated %LAA for males was 1.75 (95% CI: 1.36-2.26, p<0.001) times that of females; per 10% increase in FEV1% predicated is associated with a 0.72-fold change (95% CI: 0.69-0.76, p<0.001) in %LAA.
CONCLUSION: Increasing obesity is negatively associated with severity of emphysema independent of gender, age, and smoking history.
Copyright © 2015 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25703460      PMCID: PMC4444213          DOI: 10.1016/j.crad.2015.01.007

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  45 in total

1.  Effects of obesity and fat distribution on ventilatory function: the normative aging study.

Authors:  R Lazarus; D Sparrow; S T Weiss
Journal:  Chest       Date:  1997-04       Impact factor: 9.410

2.  Comparison of computed density and macroscopic morphometry in pulmonary emphysema.

Authors:  P A Gevenois; V de Maertelaer; P De Vuyst; J Zanen; J C Yernault
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

3.  Weight changes in the terminal stages of chronic obstructive pulmonary disease. Relation to respiratory function and prognosis.

Authors:  E Vandenbergh; K P Van de Woestijne; A Gyselen
Journal:  Am Rev Respir Dis       Date:  1967-04

4.  Body mass index and the risk of COPD.

Authors:  Raida I Harik-Khan; Jerome L Fleg; Robert A Wise
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

5.  Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.

Authors:  A M Schols; J Slangen; L Volovics; E F Wouters
Journal:  Am J Respir Crit Care Med       Date:  1998-06       Impact factor: 21.405

6.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Authors:  Bartolome R Celli; Claudia G Cote; Jose M Marin; Ciro Casanova; Maria Montes de Oca; Reina A Mendez; Victor Pinto Plata; Howard J Cabral
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

7.  Z α1-antitrypsin confers a proinflammatory phenotype that contributes to chronic obstructive pulmonary disease.

Authors:  Samuel Alam; Zhenjun Li; Carl Atkinson; Danny Jonigk; Sabina Janciauskiene; Ravi Mahadeva
Journal:  Am J Respir Crit Care Med       Date:  2014-04-15       Impact factor: 21.405

8.  'Obesity paradox' misunderstands the biology of optimal weight throughout the life cycle.

Authors:  J B Dixon; G J Egger; E A Finkelstein; J G Kral; G W Lambert
Journal:  Int J Obes (Lond)       Date:  2014-04-15       Impact factor: 5.095

Review 9.  Nutritional and metabolic modulation in chronic obstructive pulmonary disease management.

Authors:  A M W J Schols
Journal:  Eur Respir J Suppl       Date:  2003-11

10.  Impact of emphysema heterogeneity on pulmonary function.

Authors:  Jieyang Ju; Ruosha Li; Suicheng Gu; Joseph K Leader; Xiaohua Wang; Yahong Chen; Bin Zheng; Shandong Wu; David Gur; Frank Sciurba; Jiantao Pu
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

View more
  7 in total

1.  Investigation of the Obesity Paradox in Chronic Obstructive Pulmonary Disease, According to Smoking Status, in the United States.

Authors:  Tianshi David Wu; Chinedu O Ejike; Robert A Wise; Meredith C McCormack; Emily P Brigham
Journal:  Am J Epidemiol       Date:  2019-11-01       Impact factor: 4.897

2.  Using a spatial point process framework to characterize lung computed tomography scans.

Authors:  Brian E Vestal; Nichole E Carlson; Raúl San José Estépar; Tasha Fingerlin; Debashis Ghosh; Katerina Kechris; David Lynch
Journal:  Spat Stat       Date:  2018-12-31

3.  Gender and asthma-chronic obstructive pulmonary disease overlap syndrome.

Authors:  Anne G Wheaton; Roy A Pleasants; Janet B Croft; Jill A Ohar; Khosrow Heidari; David M Mannino; Yong Liu; Charlie Strange
Journal:  J Asthma       Date:  2016-04-06       Impact factor: 2.515

4.  Emphysema prevalence related air pollution caused by a cement plant.

Authors:  Hyun Seung Lee; Chul Gab Lee; Dong Hun Kim; Han Soo Song; Min Soo Jung; Jae Yoon Kim; Choong Hee Park; Seung Chul Ahn; Seung Do Yu
Journal:  Ann Occup Environ Med       Date:  2016-04-07

5.  Dietary ω-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD.

Authors:  Sandra Rutting; Michael Papanicolaou; Dia Xenaki; Lisa G Wood; Alexander M Mullin; Philip M Hansbro; Brian G Oliver
Journal:  Respir Res       Date:  2018-11-03

6.  Obesity and Morbidity Risk in the U.S. Veteran.

Authors:  Jose A Betancourt; Paula Stigler Granados; Gerardo J Pacheco; Ramalingam Shanmugam; C Scott Kruse; Lawrence V Fulton
Journal:  Healthcare (Basel)       Date:  2020-06-29

7.  Sex differences of COPD phenotypes in nonsmoking patients.

Authors:  Yoonki Hong; Wonjun Ji; Soojeong An; Seon-Sook Han; Seung-Joon Lee; Woo Jin Kim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.